About GID Group

The GID Group, Inc. is a global leader in cellular medicine, offering a tissue processing platform that enables cell-based treatments for a broad range of therapies. Our team of seasoned executives, adipose tissue scientists and surgeons works together to discover reliable, cost-effective solutions that utilize patients’ own cells to heal them.


Our Team

  • All
  • Management
  • Founders
  • Board of Directors

William Cimino, PhD

CEO, Board of Directors

William Cimino, PhD, is CEO of The GID Group and an experienced medical device executive specializing in medical design and business development. Cimino has over 30 years of professional experience in all aspects of the medical device business. He has been directly responsible for the design and market introduction of over 50 medical products and has formed and run successful medical device startup companies.

Dale Tomrdle

SVP of Operations and Finance, Treasurer

Dale Tomrdle is the senior vice president of operations and finance of The GID Group and has 30 years of business leadership experience. Tomrdle has held executive and founding positions with both venture- and angel-backed startups, as well as led operations, finance, IT, business development and sales organizations at startup and large public companies. Most recently, he worked with clients ranging from international Fortune 200 companies to startups.

Frank DiLazzaro

SVP of Global Business Development

Frank DiLazzaro is senior vice president of global business development at The GID Group and has worked in the health care industry for 30 years. DiLazzaro has held numerous executive positions focusing on sales and marketing, product development, operations and management. He has a strong global background, including global president of sales for Sytagenix Wound Management, and has built sales organizations in many key health care markets.

Adam Katz, MD

Founder, Board of Directors

Dr. Katz is Professor of Plastic Surgery and Director of the Research Laboratory in the Department of Plastic and Reconstructive Surgery, Wake Forest School of Medicine. He is internationally recognized for his contributions, innovations, and expertise in the science and translation of adipose-derived cell therapies and fat grafting, including the development of device platforms that enable such. In addition to his scientific and entrepreneurial endeavors, he maintains a clinical practice that comprises both reconstructive and aesthetic surgery. He mentors and instructs students and residents at all levels in both the laboratory and clinical setting.

J. William Futrell, MD

Co-Founder, Chairman of the Board of Directors

J. William Futrell, MD, is co-founder and chairman of The GID Group. As an entrepreneur, he is a co-inventor of multiple patents and a co-founder of numerous businesses, including CellSource, Inc., StemSource, Inc., Human Analytix, Inc., Illumineer, Inc. and Life Science Enhancement Corporation. Futrell was professor and chief of plastic surgery at the University of Pittsburgh Medical Center for 21 years and a past president of the American Association of Plastic Surgeons.

Ramón Llull, MD, PhD


Ramón Llull, MD, PhD, is currently director of the STEM Center in Mallorca, Spain, providing advanced regenerative therapies based on adipose biotechnology. Along with Dr. Adam Katz, Llull co-holds several international and US patents related to tissue engineering, device biotechnology and stem cells. He is a founder and past chairman of the International Federation of Adipose Technologies and Science (IFATS) and a founder of StemSource, Inc.

Jesse Shefferman

Board of Directors

Jesse Shefferman is vice president of the Global Healthcare Investment Banking Group at Barclays Capital. Throughout his career, Shefferman has completed numerous transactions across equity, debt and M&A products and been involved in over 50 equity and equity-linked offerings. Prior to joining Barclays Capital, he spent eight years in Equity Research and Equity Sales, both in the US and the UK for Credit Suisse First Boston and Citigroup.

G. Patrick Maxwell, MD


G. Patrick Maxwell, MD, is a world-renowned plastic surgeon known for his achievements in aesthetic surgery and is a pioneer of microsurgery. He holds 10 US patents — with seven more pending — for medical devices, has written over 100 scientific articles and performed live surgical demonstrations in over 20 countries. He invented the textured tissue expander, which has been used worldwide for breast reconstruction for 20 years, and developed flap procedures.

Edwin Mendieta

Board of Directors

Edwin Mendieta is corporate counsel of the Pellas Group, one of the largest and most diversified business conglomerates in Central America. He has extensive experience in corporate law, focusing his practice on cross-border mergers and acquisitions, foreign investment, real estate development and banking. Mendieta is a member of the Board of Directors of INIDEM (Instituto Internacional de Derecho y Empresa), an academic institution around law and business.

Morgan St. John

Board of Directors

Morgan St. John is the managing partner of Wyvern Capital and has been active in merchant and investment banking since 1978. He has originated, analyzed, structured, negotiated and syndicated approximately $40 billion of corporate transactions globally. Prior to Wyvern Capital, St. John was a partner and managing director at Bankers Trust Company, where he built groups to become industry leaders in highly structured acquisition financing.